2-20624853-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000304031.8(HS1BP3):āc.663A>Cā(p.Lys221Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000426 in 1,613,688 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000304031.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS1BP3 | NM_022460.4 | c.663A>C | p.Lys221Asn | missense_variant | 5/7 | ENST00000304031.8 | NP_071905.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS1BP3 | ENST00000304031.8 | c.663A>C | p.Lys221Asn | missense_variant | 5/7 | 1 | NM_022460.4 | ENSP00000305193 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251040Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135720
GnomAD4 exome AF: 0.000450 AC: 657AN: 1461468Hom.: 1 Cov.: 41 AF XY: 0.000424 AC XY: 308AN XY: 727044
GnomAD4 genome AF: 0.000204 AC: 31AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2021 | The c.663A>C (p.K221N) alteration is located in exon 5 (coding exon 5) of the HS1BP3 gene. This alteration results from a A to C substitution at nucleotide position 663, causing the lysine (K) at amino acid position 221 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at